ARIAD PHARMACEUTICALS INC

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$112.6M

1,497 transactions

Summary

ARIAD PHARMACEUTICALS INC is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $9.7MSales: $52.3M40 insiders

Date	Insider	Type	Value
2017-02-16	DENNER ALEXANDER J	D	$0
2017-02-16	DENNER ALEXANDER J	D	$0
2017-02-16	DENNER ALEXANDER J	D	$0
2017-02-16	DENNER ALEXANDER J	D	$0
2017-02-16	DENNER ALEXANDER J	D	$0
2017-02-16	DENNER ALEXANDER J	D	$0
2017-02-16	DENNER ALEXANDER J	D	—
2017-02-16	DENNER ALEXANDER J	D	—
2017-02-16	DENNER ALEXANDER J	D	—
2017-02-16	Kogan Elona Esq.(Sr. V. P. - General Counsel)	D	$0
2017-02-16	Kogan Elona Esq.(Sr. V. P. - General Counsel)	D	$0
2017-02-16	Kogan Elona Esq.(Sr. V. P. - General Counsel)	D	$0
2017-02-16	Soni Manmeet Singh(EVP, CFO & Treasurer)	D	$0
2017-02-16	Soni Manmeet Singh(EVP, CFO & Treasurer)	D	$0
2017-02-16	Soni Manmeet Singh(EVP, CFO & Treasurer)	D	—
2017-02-16	Protopapas Anna	D	$0
2017-02-16	Protopapas Anna	D	$0
2017-02-16	Protopapas Anna	D	$0
2017-02-16	Protopapas Anna	D	—
2017-02-16	Panayiotopoulos Paris(President and CEO)	D	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

ARIAD PHARMACEUTICALS INC — Contributions, Lobbying & Contracts | Poliscope